Published 14 hours ago • loading... • Updated 14 hours ago
Absentia Labs' Digital Liver Model Becomes First AI Drug Development Tool Accepted Into FDA Qualification Program
Summary by Weatherford Democrat
1 Articles
1 Articles
Absentia Labs' Digital Liver Model Becomes First AI Drug Development Tool Accepted Into FDA Qualification Program
Founded by MIT-Trained Scientists, Biotech Startup Advances Predictive AI to Improve Human Safety Assessment, Reduce Costly Drug Attrition and Accelerate Drug Development
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
